STOCKS
12 Cheap Dividend Stocks With Safe Yields for 2025
Morningstar analysts reveal a list of dividend stocks with sustainable above average payouts, which are trading at discounts to our assessed fair values.
Given ongoing economic uncertainty and market volatility, investors might consider adding cheap, quality dividend stocks to their portfolios.
Quality companies have the financial stability and competitive advantage to maintain their dividends during questionable economic periods. Price risks are reduced when investors can buy the stocks of these companies for less than what they’re worth.
In times of uncertainty, quality companies can give investors peace of mind. Morningstar analysts have identified over 12 undervalued dividend stocks with sustainable above average dividend payouts, trading at a 4-or 5-star rating as of 25 March 2024.
The list includes stocks various sectors and can be found in Morningstar Investor - Morningstar’s flagship subscription for individual investors - inside the ‘Discover Investment’ > 'Investment Ideas' section under ‘Sustainable Income’ stocks. To get access, sign up for a FREE 4-week trial^ of Morningstar Investor now (no credit card needed).
^The free 4-week trial offer is limited to new clients and cannot be used in combination with any other promotional offers and cannot be used to extend an existing Investor Membership. One free trial per household. Morningstar is licensed to provide our subscription service to Australian residents only.
About Us
Morningstar started with an idea—one great idea from a 27-year-old stock analyst. Joe Mansueto thought it was unfair that people didn’t have access to the same information as financial professionals. So he hired a few people and set up shop in his apartment in 1984—to deliver investment research to everyone.
Since then, we've empowered millions of investors all over the world, and we’re continuing to look for new ways to help people achieve financial security.
Our research is independent, which means we do not charge or accept payment or commissions from fund managers, listed companies or other product issuers to produce research on their products.
